Kamelia Hristova-Panusheva became a member of the Institute of Biophysics and Biomedical Engineering in the Bulgarian Academy of Sciences in 2005, where she started to investigate biocompatibilty of new materials for regenerative medicine and the influence of different modification of these materials to cell adhesion. She was awarded a PhD in Biophysics in 2011. Over the past few years, the research interest of Kamelia Hristova-Panusheva is focused on nanoparticle materials, implementation of graphene oxide nanoparticles as drug carriers and for nanomaterial-mediated photothermal anticancer therapy. She also focuses on the antitumor potential of promising guanine-quadruplex ligands in in vitro conditions.
Kamelia Hristova-Panusheva became a member of the Institute of Biophysics and Biomedical Engineering in the Bulgarian Academy of Sciences in 2005, where she started to investigate biocompatibilty of new materials for regenerative medicine and the influence of different modification of these materials to cell adhesion. She was awarded a PhD in Biophysics in 2011. Over the past few years, the research interest of Kamelia Hristova-Panusheva is focused on nanoparticle materials, implementation of graphene oxide nanoparticles as drug carriers and for nanomaterial-mediated photothermal anticancer therapy. She also focuses on the antitumor potential of promising guanine-quadruplex ligands in in vitro conditions.